Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 254
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing; Potential LSD, Psilocybin Brand Names
Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health
Weekly Psychedelic Policy Briefing: October 5, 2026
Podcast: Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines
Psychedelic Churches Need Psychedelic Seminaries
How PCP Became A Weapon of Police Propaganda [Part 2]
Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma...
Whole-Body Effects of Psychedelics Part 2 – Blood and Immune System
Psyched Wellness Submits Applications for Four Further Provisional Patents Surrounding Its...
PT258 – Manesh Girn – Psychedelics and the Brain: Neuroplasticity and...
Diamond Therapeutics Announces Health Canada Approval of Clinical Trial with Low-Dose...
Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and...
MindMed Joins Critical Path Institute’s Patient-Reported Outcome Consortium
Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update
Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results
Load more